Shire made a $30bn (£19bn) hostile takeover bid for Baxalta. Industry overview Shire is a London-listed drug company, with tax domicile in Ireland and Jersey. Shire develops and provides healthcare in the areas of behavioral health, gastrointestinal conditions, rare diseases, and regenerative medicine. Its main business lies in the area of Attention Deficit Hyperactive Disorder (ADHD) - … Continue reading A “LOWBALL OPENING” – SHIRE’S TAKEOVER OFFER FOR BAXALTA
Bocconi Students M&A Circle 
You must be logged in to post a comment.